loadpatents
Patent applications and USPTO patent grants for Marquis; David Matthew.The latest application filed is for "anti-il-6 antibodies, compositions, methods and uses".
Patent | Date |
---|---|
Anti-IL-6 antibodies Grant 8,623,362 - Chen , et al. January 7, 2 | 2014-01-07 |
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20130017208 - Chen; Yan ;   et al. | 2013-01-17 |
Anti-IL-6 antibodies, compositions, methods and uses Grant RE43,672 - Chan , et al. September 18, 2 | 2012-09-18 |
Anti-sclerostin antibodies Grant 8,257,704 - Korytko , et al. September 4, 2 | 2012-09-04 |
Anti-IL-6 antibodies, compositions, methods and uses Grant 8,226,611 - Chen , et al. July 24, 2 | 2012-07-24 |
Methods of using TGF-.beta. 1 binding compositions Grant 8,128,927 - Davies , et al. March 6, 2 | 2012-03-06 |
Anti-IL-6 Antibodies, Compositions, Methods and Uses App 20120045453 - CHEN; YAN ;   et al. | 2012-02-23 |
Methods of treating conditions using anti-IL-6 antibodies Grant 8,067,003 - Chen , et al. November 29, 2 | 2011-11-29 |
Anti-sclerostin Antibodies App 20110250205 - KORYTKO; Andrew Ihor ;   et al. | 2011-10-13 |
Anti-CXCR4 antibodies Grant 8,003,102 - Dickerson , et al. August 23, 2 | 2011-08-23 |
Methods of treatment comprising administering an anti-sclerostin antibody Grant 7,988,970 - Korytko , et al. August 2, 2 | 2011-08-02 |
Anti-cxcr4 Antibodies App 20110086027 - Dickerson; Cindy Takeuchi ;   et al. | 2011-04-14 |
Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies App 20110081355 - CHEN; YAN ;   et al. | 2011-04-07 |
Humanized anti-ghrelin antibodies Grant 7,901,679 - Marquis , et al. March 8, 2 | 2011-03-08 |
Anti-CXCR4 antibodies Grant 7,892,546 - Dickerson , et al. February 22, 2 | 2011-02-22 |
Anti-IL-23 antibodies Grant 7,872,102 - Beidler , et al. January 18, 2 | 2011-01-18 |
Anti-IL-6 antibody nucleic acid molecules and methods Grant 7,833,755 - Chen , et al. November 16, 2 | 2010-11-16 |
Anti-cxcr4 Antibodies App 20100285005 - Dickerson; Cindy Takeuchi ;   et al. | 2010-11-11 |
Anti-Sclerostin Antibodies App 20100221263 - Korytko; Andrew Ihor ;   et al. | 2010-09-02 |
Anti-sclerostin antibodies Grant 7,744,874 - Korytko , et al. June 29, 2 | 2010-06-29 |
Binding Compositions: Related Reagents App 20100040633 - Davies; Julian ;   et al. | 2010-02-18 |
Antibodies to TGF-beta 1 Grant 7,619,069 - Davies , et al. November 17, 2 | 2009-11-17 |
Anti-IL-23 Antibodies App 20090240036 - Beidler; Catherine Brautigam ;   et al. | 2009-09-24 |
Anti-IL-6 Antibody Nucleic Acid Molecules and Methods App 20090239258 - Chen; Yan ;   et al. | 2009-09-24 |
Methods Of Optimizing Antibody Variable Region Binding Affinity App 20090202986 - Huse; William D. ;   et al. | 2009-08-13 |
Humanized Anti-ghrelin Antibodies App 20090181018 - Marquis; David Matthew ;   et al. | 2009-07-16 |
Anti-il-6 antibodies, compositions, methods and uses Grant 7,560,112 - Chen , et al. July 14, 2 | 2009-07-14 |
Anti-sclerostin Antibodies App 20090060924 - Korytko; Andrew Ihor ;   et al. | 2009-03-05 |
Humanized anti-ghrelin antibodies Grant 7,479,271 - Marquis , et al. January 20, 2 | 2009-01-20 |
Humanized Anti-Ghrelin Antibodies App 20080118498 - Marquis; David Matthew ;   et al. | 2008-05-22 |
Fc Region Variants App 20080089892 - Allan; Barrett W. ;   et al. | 2008-04-17 |
Binding Compositions: Related Reagents App 20080050375 - Davies; Julian ;   et al. | 2008-02-28 |
Anti-IL-6 antibodies, compositions, methods and uses App 20060257407 - Chen; Yan ;   et al. | 2006-11-16 |
aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies App 20050208480 - Victoria, Edward Jess ;   et al. | 2005-09-22 |
APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies App 20040009904 - Victoria, Edward Jess ;   et al. | 2004-01-15 |
aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies Grant 6,207,160 - Victoria , et al. March 27, 2 | 2001-03-27 |
APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies Grant 5,874,409 - Victoria , et al. February 23, 1 | 1999-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.